Prostatis Group’s Invesco S&P 500 GARP ETF SPGP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,450
Closed -$619K 180
2025
Q3
$619K Sell
5,450
-1,314
-19% -$146K 0.16% 92
2025
Q2
$728K Sell
6,764
-4,009
-37% -$400K 0.21% 87
2025
Q1
$1.08M Sell
10,773
-1,492
-12% -$157K 0.34% 65
2024
Q4
$1.29M Buy
12,265
+355
+3% +$38.3K 0.38% 62
2024
Q3
$1.25M Sell
11,910
-399
-3% -$40.8K 0.41% 61
2024
Q2
$1.27M Buy
12,309
+2,207
+22% +$227K 0.44% 56
2024
Q1
$1.07M Buy
10,102
+41
+0.4% +$4.08K 0.41% 57
2023
Q4
$986K Sell
10,061
-6,478
-39% -$599K 0.41% 60
2023
Q3
$1.51M Buy
16,539
+4,986
+43% +$465K 0.74% 32
2023
Q2
$1.05M Sell
11,553
-1,887
-14% -$163K 0.49% 48
2023
Q1
$1.15M Sell
13,440
-207
-2% -$17.9K 0.61% 44
2022
Q4
$1.13M Sell
13,647
-63,659
-82% -$5.24M 0.69% 38
2022
Q3
$5.78M Buy
+77,306
New +$6.43M 6.67% 3

Other funds holding SPGP

Prostatis Group's SPGP Position: Q4 2025 in Review

Prostatis Group sold out of Invesco S&P 500 GARP ETF (SPGP) in Q4 2025, closing a stake of 5,450 shares — an estimated $619K sold.

Prostatis Group first reported a position in SPGP in Q3 2022 and held it in 13 quarters. The position peaked at $5.78M in Q3 2022. 322 funds tracked by Wall St. Rank hold SPGP as of Q4 2025.

  • Prostatis Group reported no remaining Invesco S&P 500 GARP ETF position as of Q4 2025 after selling out during the quarter.
  • Prostatis Group sold 5,450 Invesco S&P 500 GARP ETF shares in Q4 2025, an estimated $619K.
  • Prostatis Group first reported a position in Invesco S&P 500 GARP ETF in Q3 2022 and held it in 13 quarters.
  • Prostatis Group's Invesco S&P 500 GARP ETF position peaked at $5.78M in Q3 2022.
  • 322 funds tracked by Wall St. Rank held Invesco S&P 500 GARP ETF as of Q4 2025.

Based on Prostatis Group's 13F filing for Q4 2025, filed 17 Feb 2026.